Stockscreener 앱 받기
7.01
3.04%
-0.22
시간 외 거래:
7.01
전일 마감가:
$7.23
열려 있는:
$7.22
하루 거래량:
1.61M
Relative Volume:
0.82
시가총액:
$853.66M
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-24.17
EPS:
-0.29
순현금흐름:
$-31.85M
1주 성능:
-3.38%
1개월 성능:
-5.40%
6개월 성능:
+59.68%
1년 성능:
+126.13%
1일 변동 폭
$6.93
$7.32
1주일 범위
$6.93
$7.36
52주 변동 폭
$2.36
$8.78
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
TRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
7.01 | 880.45M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
Using AI based signals to follow Trevi Therapeutics Inc.Buy Signal & Weekly Stock Performance Updates - Newser
What is the target price for Trevi Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trade Tips - خودرو بانک
What Fibonacci levels say about Trevi Therapeutics Inc. reboundQuarterly Profit Report & Community Verified Watchlist Alerts - Newser
Why Trevi Therapeutics Inc. is moving today2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
Trevi Therapeutics Inc. stock trendline breakdownAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Pattern recognition hints at Trevi Therapeutics Inc. upsideBuy Signal & Safe Capital Investment Plans - Newser
Has Trevi Therapeutics Inc. found a price floorJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
What data driven models say about Trevi Therapeutics Inc.’s futureMarket Rally & Safe Entry Trade Reports - Newser
How does Trevi Therapeutics Inc. score in quality rankingsForecast Cut & Free Reliable Trade Execution Plans - خودرو بانک
Is Trevi Therapeutics Inc. forming a bottoming baseQuarterly Trade Review & Real-Time Market Sentiment Reports - Newser
Volume spikes in Trevi Therapeutics Inc. stock – what they meanMarket Growth Review & Consistent Profit Trading Strategies - Newser
Will Trevi Therapeutics Inc. stock go up soonJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Tools to monitor Trevi Therapeutics Inc. recovery probabilityEntry Point & Free Technical Confirmation Trade Alerts - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmapsTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Will Trevi Therapeutics Inc. outperform the market in YEARJuly 2025 Movers & Verified Momentum Stock Ideas - خودرو بانک
Can Trevi Therapeutics Inc. hit a new high this monthWeekly Market Report & Advanced Swing Trade Entry Plans - Newser
Can Trevi Therapeutics Inc. reach resistance levels soonJuly 2025 Highlights & Weekly High Return Forecasts - خودرو بانک
Trevi Therapeutics Inc.’s volatility index tracking explainedQuarterly Profit Review & Short-Term High Return Ideas - Newser
Statistical indicators supporting Trevi Therapeutics Inc.’s strengthTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Can Trevi Therapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - خودرو بانک
How to monitor Trevi Therapeutics Inc. with trend dashboards2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Is Trevi Therapeutics Inc. stock reversal real or fakeWeekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Is Trevi Therapeutics Inc. stock ready for a breakoutJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
Sentiment analysis tools applied to Trevi Therapeutics Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profileTrade Exit Summary & AI Powered Buy/Sell Recommendations - Newser
Will Trevi Therapeutics Inc. benefit from rate cutsMarket Sentiment Summary & AI Powered Market Entry Ideas - خودرو بانک
Volatility clustering patterns for Trevi Therapeutics Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser
Real time breakdown of Trevi Therapeutics Inc. stock performanceWeekly Trend Report & Entry and Exit Point Strategies - Newser
Full technical analysis of Trevi Therapeutics Inc. stockJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Applying chart zones and confluence areas to Trevi Therapeutics Inc.Weekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Signal strength of Trevi Therapeutics Inc. stock in tech scannersEarnings Risk Summary & Weekly Return Optimization Plans - Newser
RSI Reset May Fuel Rebound in Trevi Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트레비 테라퓨틱스 주식 (TRVI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
1.40%
자본화:
|
볼륨(24시간):